176 related articles for article (PubMed ID: 36515702)
1. Genotype-phenotype characterisation of long survivors with motor neuron disease in Scotland.
Leighton DJ; Ansari M; Newton J; Parry D; Cleary E; Colville S; Stephenson L; Larraz J; Johnson M; Beswick E; Wong M; Gregory J; Carod Artal J; Davenport R; Duncan C; Morrison I; Smith C; Swingler R; Deary IJ; Porteous M; Aitman TJ; Chandran S; Gorrie GH; Pal S; ;
J Neurol; 2023 Mar; 270(3):1702-1712. PubMed ID: 36515702
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of primary lateral sclerosis.
de Boer EMJ; de Vries BS; Pennings M; Kamsteeg EJ; Veldink JH; van den Berg LH; van Es MA
J Neurol; 2023 Aug; 270(8):3970-3980. PubMed ID: 37133535
[TBL] [Abstract][Full Text] [Related]
3. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
[TBL] [Abstract][Full Text] [Related]
4. Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia.
Geevasinga N; Menon P; Sue CM; Kumar KR; Ng K; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2015 May; 22(5):826-31, e57-8. PubMed ID: 25683471
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis.
Nishiyama A; Niihori T; Warita H; Izumi R; Akiyama T; Kato M; Suzuki N; Aoki Y; Aoki M
Neurobiol Aging; 2017 May; 53():194.e1-194.e8. PubMed ID: 28160950
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.
Sprute R; Jergas H; Ölmez A; Alawbathani S; Karasoy H; Dafsari HS; Becker K; Daimagüler HS; Nürnberg P; Muntoni F; Topaloglu H; Uyanik G; Cirak S
Am J Med Genet A; 2021 Feb; 185(2):344-354. PubMed ID: 33155358
[TBL] [Abstract][Full Text] [Related]
7. Aproximación genética en la esclerosis lateral amiotrófica.
Cervantes-Aragón I; Ramírez-García SA; Baltazar-Rodríguez LM; García-Cruz D; Castañeda-Cisneros G
Gac Med Mex; 2019; 155(5):513-521. PubMed ID: 31695223
[TBL] [Abstract][Full Text] [Related]
8. Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.
Black HA; Leighton DJ; Cleary EM; Rose E; Stephenson L; Colville S; Ross D; Warner J; Porteous M; Gorrie GH; Swingler R; Goldstein D; Harms MB; Connick P; Pal S; Aitman TJ; Chandran S
Neurobiol Aging; 2017 Mar; 51():178.e11-178.e20. PubMed ID: 28089114
[TBL] [Abstract][Full Text] [Related]
9. Genetic landscape of ALS in Malta based on a quinquennial analysis.
Farrugia Wismayer M; Farrugia Wismayer A; Borg R; Bonavia K; Abela A; Chircop C; Aquilina J; Soler D; Pace A; Vella M; Vassallo N; Cauchi RJ
Neurobiol Aging; 2023 Mar; 123():200-207. PubMed ID: 36549973
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.
Barceló MA; Povedano M; Vázquez-Costa JF; Franquet Á; Solans M; Saez M
Sci Rep; 2021 Mar; 11(1):6207. PubMed ID: 33737526
[TBL] [Abstract][Full Text] [Related]
11. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.
Chipika RH; Finegan E; Li Hi Shing S; McKenna MC; Christidi F; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P
Neuroimage Clin; 2020; 27():102300. PubMed ID: 32554322
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.
Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T
J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149
[TBL] [Abstract][Full Text] [Related]
13. Familial motor neuron disease: co-occurrence of PLS and ALS (-FTD).
de Boer EMJ; Demaegd KC; de Bie CI; Veldink JH; van den Berg LH; van Es MA
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):53-60. PubMed ID: 37679883
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
van Blitterswijk M; Mullen B; Heckman MG; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Neurobiol Aging; 2014 Oct; 35(10):2421.e13-7. PubMed ID: 24866401
[TBL] [Abstract][Full Text] [Related]
16. Hereditary spastic paraplegia is not associated with C9ORF72 repeat expansions in a Danish cohort.
Nielsen TT; Svenstrup K; Duno M; Nielsen JE
Spinal Cord; 2014 Jan; 52(1):77-9. PubMed ID: 24126854
[TBL] [Abstract][Full Text] [Related]
17. Application of a custom NGS gene panel revealed a high diagnostic utility for molecular testing of hereditary ataxias.
Radziwonik W; Elert-Dobkowska E; Klimkowicz-Mrowiec A; Ziora-Jakutowicz K; Stepniak I; Zaremba J; Sulek A
J Appl Genet; 2022 Sep; 63(3):513-525. PubMed ID: 35588347
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes.
Brugman F; Veldink JH; Franssen H; de Visser M; de Jong JM; Faber CG; Kremer BH; Schelhaas HJ; van Doorn PA; Verschuuren JJ; Bruyn RP; Kuks JB; Robberecht W; Wokke JH; van den Berg LH
Arch Neurol; 2009 Apr; 66(4):509-14. PubMed ID: 19364936
[TBL] [Abstract][Full Text] [Related]
19. Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases.
Hübers A; Marroquin N; Schmoll B; Vielhaber S; Just M; Mayer B; Högel J; Dorst J; Mertens T; Just W; Aulitzky A; Wais V; Ludolph AC; Kubisch C; Weishaupt JH; Volk AE
Neurobiol Aging; 2014 May; 35(5):1214.e1-6. PubMed ID: 24378086
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
